20,011 Shares in Mettler-Toledo International, Inc. $MTD Acquired by Eurizon Capital SGR S.p.A.

Eurizon Capital SGR S.p.A. bought a new position in shares of Mettler-Toledo International, Inc. (NYSE:MTDFree Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 20,011 shares of the medical instruments supplier’s stock, valued at approximately $27,905,000. Eurizon Capital SGR S.p.A. owned 0.10% of Mettler-Toledo International as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Principal Financial Group Inc. grew its holdings in Mettler-Toledo International by 2.9% during the 3rd quarter. Principal Financial Group Inc. now owns 298,429 shares of the medical instruments supplier’s stock worth $366,354,000 after acquiring an additional 8,360 shares during the period. Nordea Investment Management AB grew its holdings in Mettler-Toledo International by 11.9% during the 4th quarter. Nordea Investment Management AB now owns 157,457 shares of the medical instruments supplier’s stock worth $220,718,000 after acquiring an additional 16,777 shares during the period. Citigroup Inc. grew its holdings in Mettler-Toledo International by 4.8% during the 3rd quarter. Citigroup Inc. now owns 65,033 shares of the medical instruments supplier’s stock worth $79,835,000 after acquiring an additional 2,989 shares during the period. Machina Capital S.A.S. acquired a new stake in Mettler-Toledo International during the 3rd quarter worth $1,186,000. Finally, Thrivent Financial for Lutherans grew its holdings in Mettler-Toledo International by 752.2% during the 3rd quarter. Thrivent Financial for Lutherans now owns 73,586 shares of the medical instruments supplier’s stock worth $90,335,000 after acquiring an additional 64,951 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on the stock. Citigroup lowered their target price on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating for the company in a report on Friday, May 8th. JPMorgan Chase & Co. lowered their target price on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating for the company in a report on Monday, May 11th. Morgan Stanley lowered their target price on shares of Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating for the company in a report on Tuesday, May 12th. Jefferies Financial Group raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and boosted their price target for the company from $1,400.00 to $1,450.00 in a report on Friday, March 20th. Finally, Stifel Nicolaus decreased their price target on shares of Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating for the company in a report on Monday, May 18th. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $1,408.55.

Check Out Our Latest Report on MTD

Mettler-Toledo International Stock Up 1.6%

Shares of MTD stock opened at $1,181.99 on Friday. Mettler-Toledo International, Inc. has a 12-month low of $1,023.05 and a 12-month high of $1,525.17. The firm has a market capitalization of $23.89 billion, a price-to-earnings ratio of 27.72, a price-to-earnings-growth ratio of 2.46 and a beta of 1.31. The firm has a fifty day moving average of $1,221.65 and a 200-day moving average of $1,332.06.

Mettler-Toledo International (NYSE:MTDGet Free Report) last announced its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $8.70 by $0.21. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The company had revenue of $947.13 million during the quarter, compared to analyst estimates of $943.14 million. During the same quarter in the previous year, the business earned $8.19 EPS. The firm’s revenue was up 7.2% on a year-over-year basis. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. Research analysts expect that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current year.

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

Recommended Stories

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTDFree Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.